Gilead Prevails in HIV Drug Development Lawsuit; Lilly Broadens Obesity Drug Access
Gilead won a legal case that examined the speed of HIV drug development. Eli Lilly has expanded access to its next-generation obesity drug retatrutide beyond the single 79-year-old patient who initially received special access.
Related stories
Federal court upholds Medicare drug price negotiation program against Merck's challenge · Healthcare systems
TwinStrand wins patent lawsuit, GSK's hepatitis B drug gains Japan approval · Drug development
Lilly Sues Six Firms Over Unauthorized Sales of Experimental Obesity Drug · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Three biotechs with three news updates.” Browse more stories.